Journal
CANCER INVESTIGATION
Volume 39, Issue 4, Pages 333-348Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/07357907.2021.1878529
Keywords
Anticancer; Amomum subulatum; daltons lymphoma ascites; solid tumor; cytokines
Categories
Funding
- Council of Scientific and Industrial Research [09/553(0022)/2016-EMR-1]
- University Grants Commission [20/12/2015 (ii) EU-V]
Ask authors/readers for more resources
The methanolic extract of A. subulatum dry fruits showed anticancer potential by inducing apoptosis in DLA cells, reducing tumor burden, and increasing lifespan. It was found to be safer than the standard drug cyclophosphamide, making it a potential nutraceutical against cancer.
This study investigates the anticancer potential of methanolic extract of A. subulatum dry fruits (MEAS) in Dalton's Lymphoma Ascites (DLA) cells in vitro and on DLA induced ascitic and solid tumor-bearing mice. MEAS induced apoptosis in DLA cells and MEAS administration effectively reduced tumor burden, and increased life span via modulating pro-inflammatory cytokines and regulating NF-kappa B pathway. MEAS seemed to be much safer than the standard drug cyclophosphamide, as the latter was associated with adverse effects such as body weight loss, depletion of hemoglobin level and hepatotoxicity, suggesting A. subulatum as a potential nutraceutical against cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available